|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| A61K 31/53 | |||
| A61K 31/55 | |||
| C07D 487/04 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3174869 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15747562.5 |
| Europos patento paraiškos padavimo data | 2015-07-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/055737 |
| Data | 2015-07-29 |
| (87) | Numeris | WO 2016/016822 |
| Data | 2016-02-04 |
| (30) | Numeris | Data | Šalis |
| 201462031583 P | 2014-07-31 | US |
| (72) |
HAO, Huaixiang, US
HUANG, Xizhong, US
TAM, Angela, US
KASIBHATLA, Shailaja, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION THERAPY OF A MET INHIBITOR AND AN EGFR INHIBITOR |
| COMBINATION THERAPY OF A MET INHIBITOR AND AN EGFR INHIBITOR |